Item 7.01 Regulation FD Disclosure . On April 23, 2026, BioRestorative Therapies, Inc. (the “Company”) made available an updated corporate presentation (the “Presentation”) that may be used by the Company in connection with presentations at conferences and investor meetings. The Presentation can be found on the Company’s website, www.biorestorative.com . The Presentation is furnished as Exhibit 99.1 hereto. The information in the Presentation is being furnished, not filed, pursuant to this Item 7.01. Accordingly, the information in the Presentation will not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing. The furnishing of the information in this Current Report on Form 8-K with respect to the Presentation is not intended to, and does not, constitute a determination or admission by the Company that the information in this Current Report on Form 8-K with respect to the Presentation is material or complete, or that investors should consider this information before making an investment decision with respect to any security of the Company.
BRTX Biorestorative Therapies, Inc. - 8-K
Accession
0001021771-26-0000587.019.01
Item 7.01 - Regulation FD Disclosure
220 words
Item 9.01 - Financial Statements and Exhibits
27 words
Item 9.01 Financial Statements and Exhibits . (d) Exhibits . Number Description 99.1 Presentation Materials 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)